US Stock MarketDetailed Quotes

CYTO Altamira Therapeutics

Watchlist

0.4300
+0.0274+6.81%

Close Nov 29 13:00 ET

0.4151
-0.0149-3.47%

Post 17:01 ET

1.62MMarket Cap0.04P/E (TTM)

Altamira Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(FY)Dec 31, 2022

(FY)Dec 31, 2021

(FY)Dec 31, 2020

(FY)Dec 31, 2019

(FY)Dec 31, 2018

(Q4)Dec 31, 2018

(Q3)Sep 30, 2018

(Q2)Jun 30, 2018

(Q1)Mar 31, 2018

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

93.44%-614.48K

37.39%-9.37M

-169.81%-14.96M

36.00%-5.54M

34.53%-8.66M

45.49%-13.23M

70.09%-1.93M

15.62%-4.02M

63.37%-2.3M

26.48%-4.98M

Net income from continuing operations

92.60%-2.12M

-53.33%-28.61M

-98.83%-18.66M

-37.13%-9.39M

40.46%-6.84M

52.90%-11.5M

19.51%-3.69M

50.43%-2.98M

43.09%-3.08M

79.22%-1.75M

Operating gains losses

----

-293.70%-418.55K

-91.94%216.08K

531.22%2.68M

43.40%-621.6K

55.24%-1.1M

261.96%2.84M

-1,551.68%-298.9K

37.31%-550.62K

-2,033.32%-3.09M

Depreciation and amortization

----

53.51%128.23K

264.25%83.53K

-27.91%22.93K

-56.25%31.81K

-40.78%72.71K

-58.72%11.05K

-50.58%15.35K

-28.57%22.86K

-28.82%23.45K

Deferred tax

-956.60%-117.71K

-147.10%-11.14K

197.09%23.65K

87.82%-24.36K

-223.35%-200.05K

1,012.49%162.18K

2,669.94%188.36K

-6.52%-8.73K

-6.56%-8.73K

-6.53%-8.73K

Other non cash items

----

930.58%1.97M

-51.88%191K

31,815.43%396.91K

-99.92%1.24K

-39.40%1.57M

-90.34%87.69K

-43.66%228.79K

53.40%602.12K

-26.44%654.31K

Change In working capital

-57.76%1.62M

1,856.48%3.84M

-42.95%196.24K

127.23%343.97K

48.92%-1.26M

-428.22%-2.47M

-12.62%-1.29M

-269.69%-1.18M

206.11%550.13K

-211.30%-553.02K

-Change in receivables

484.75%429.93K

69.97%-111.74K

-227.76%-372.08K

1,591.03%291.23K

-6.21%-19.53K

-119.70%-18.39K

-119.16%-11.24K

471.19%117.27K

-91.55%4.31K

-249.36%-128.72K

-Change in inventory

-142.60%-380.28K

197.23%892.61K

---918.08K

--0

----

-Change in prepaid assets

-47.92%481.04K

165.08%923.73K

-891.62%-1.42M

309.46%179.31K

-128.38%-85.61K

0.65%301.63K

175.95%156.04K

-121.50%-26.51K

14.58%351.22K

-337.83%-179.12K

-Change in payables and accrued expense

-48.89%1.09M

-26.53%2.13M

2,396.01%2.91M

89.07%-126.56K

57.98%-1.16M

-220.05%-2.76M

-43.73%-1.43M

-330.24%-1.27M

122.22%194.61K

-153.49%-245.18K

Cash from discontinued investing activities

Operating cash flow

93.44%-614.48K

37.39%-9.37M

-169.81%-14.96M

36.00%-5.54M

34.53%-8.66M

45.49%-13.23M

70.09%-1.93M

15.62%-4.02M

63.37%-2.3M

26.48%-4.98M

Investing cash flow

Cash flow from continuing investing activities

100.11%2.46K

39.75%-2.31M

-44.71%-3.83M

14.44%-2.65M

-69.89%-3.1M

-1,733.98%-1.82M

-29,224.30%-1.87M

207.96%68.16K

-235.64%-19.64K

Net PPE purchase and sale

----

-196.30%-65.64K

1,166.83%68.16K

--0

----

--0

Net intangibles purchase and sale

----

36.48%-2.31M

-37.30%-3.64M

13.11%-2.65M

-61.27%-3.05M

-1,190.16%-1.89M

---1.87M

--0

----

Net business purchase and sale

----

--0

----

Net investment purchase and sale

--2.46K

--0

---195.93K

----

Cash from discontinued investing activities

Investing cash flow

100.11%2.46K

39.75%-2.31M

-44.71%-3.83M

14.44%-2.65M

-69.89%-3.1M

-1,733.98%-1.82M

-29,224.30%-1.87M

207.96%68.16K

-235.64%-19.64K

--0

Financing cash flow

Cash flow from continuing financing activities

-88.77%1.19M

46.57%10.6M

-62.73%7.24M

154.95%19.41M

32.83%7.61M

-30.27%5.73M

269.82%3.91M

476.03%4.92M

-1,822.01%-6.06M

-66.28%2.96M

Net issuance payments of debt

----

8,602.26%6.39M

-104.31%-75.16K

215.42%1.74M

83.71%-1.51M

-344.27%-9.27M

-0.59%-1.07M

---1.17M

---5.61M

---1.43M

Net common stock issuance

--1.19M

----

--7M

--0

-43.33%5.28M

Cash dividends paid

----

--0

Proceeds from stock option exercised by employees

----

-42.91%4.27M

-59.31%7.49M

82.03%18.4M

-42.07%10.11M

--17.45M

----

Net other financing activities

----

77.68%-38.29K

76.47%-171.55K

25.55%-728.94K

51.21%-979.03K

-29.60%-2.01M

88.64%-149.99K

---851.69K

---349.91K

-188.00%-654.99K

Cash from discontinued financing activities

Financing cash flow

-88.77%1.19M

46.57%10.6M

-62.73%7.24M

154.95%19.41M

32.83%7.61M

-30.27%5.73M

269.82%3.91M

476.03%4.92M

-1,822.01%-6.06M

-66.28%2.96M

Net cash flow

Beginning cash position

-99.44%5.89K

-91.38%1.06M

677.13%12.32M

-71.53%1.58M

-62.83%5.57M

-53.85%14.97M

-73.97%5.26M

-83.15%4.42M

-62.61%12.65M

-53.85%14.97M

Current changes in cash

154.01%578.54K

90.73%-1.07M

-203.00%-11.56M

370.68%11.22M

55.54%-4.15M

42.29%-9.32M

102.04%110.18K

115.77%967.33K

-27.18%-8.38M

-202.57%-2.02M

Effect of exchange rate changes

-102.26%-591.7089

-91.73%26.18K

286.71%316.59K

924.31%81.87K

103.10%7.99K

80.41%-257.64K

-85.41%25.15K

-241.97%-131.22K

114.77%150.17K

46.41%-301.74K

End cash Position

3,416.07%583.84K

-98.46%16.6K

-91.65%1.08M

801.72%12.89M

-73.50%1.43M

-63.98%5.39M

-73.97%5.26M

-83.15%4.42M

-62.61%12.65M

Free cash flow

94.74%-614.48K

37.21%-11.68M

-126.96%-18.6M

30.43%-8.19M

22.12%-11.78M

38.09%-15.12M

41.13%-3.8M

16.88%-4.02M

63.06%-2.32M

27.28%-4.98M

Currency Unit

USD

CHF

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

Unqualified Opinion

	(FY)Dec 31, 2023	(FY)Dec 31, 2022	(FY)Dec 31, 2021	(FY)Dec 31, 2020	(FY)Dec 31, 2019	(FY)Dec 31, 2018	(Q4)Dec 31, 2018	(Q3)Sep 30, 2018	(Q2)Jun 30, 2018	(Q1)Mar 31, 2018
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	93.44%-614.48K	37.39%-9.37M	-169.81%-14.96M	36.00%-5.54M	34.53%-8.66M	45.49%-13.23M	70.09%-1.93M	15.62%-4.02M	63.37%-2.3M	26.48%-4.98M
Net income from continuing operations	92.60%-2.12M	-53.33%-28.61M	-98.83%-18.66M	-37.13%-9.39M	40.46%-6.84M	52.90%-11.5M	19.51%-3.69M	50.43%-2.98M	43.09%-3.08M	79.22%-1.75M
Operating gains losses	----	-293.70%-418.55K	-91.94%216.08K	531.22%2.68M	43.40%-621.6K	55.24%-1.1M	261.96%2.84M	-1,551.68%-298.9K	37.31%-550.62K	-2,033.32%-3.09M
Depreciation and amortization	----	53.51%128.23K	264.25%83.53K	-27.91%22.93K	-56.25%31.81K	-40.78%72.71K	-58.72%11.05K	-50.58%15.35K	-28.57%22.86K	-28.82%23.45K
Deferred tax	-956.60%-117.71K	-147.10%-11.14K	197.09%23.65K	87.82%-24.36K	-223.35%-200.05K	1,012.49%162.18K	2,669.94%188.36K	-6.52%-8.73K	-6.56%-8.73K	-6.53%-8.73K
Other non cash items	----	930.58%1.97M	-51.88%191K	31,815.43%396.91K	-99.92%1.24K	-39.40%1.57M	-90.34%87.69K	-43.66%228.79K	53.40%602.12K	-26.44%654.31K
Change In working capital	-57.76%1.62M	1,856.48%3.84M	-42.95%196.24K	127.23%343.97K	48.92%-1.26M	-428.22%-2.47M	-12.62%-1.29M	-269.69%-1.18M	206.11%550.13K	-211.30%-553.02K
-Change in receivables	484.75%429.93K	69.97%-111.74K	-227.76%-372.08K	1,591.03%291.23K	-6.21%-19.53K	-119.70%-18.39K	-119.16%-11.24K	471.19%117.27K	-91.55%4.31K	-249.36%-128.72K
-Change in inventory	-142.60%-380.28K	197.23%892.61K	---918.08K	--0	--0	----	----	----	----	----
-Change in prepaid assets	-47.92%481.04K	165.08%923.73K	-891.62%-1.42M	309.46%179.31K	-128.38%-85.61K	0.65%301.63K	175.95%156.04K	-121.50%-26.51K	14.58%351.22K	-337.83%-179.12K
-Change in payables and accrued expense	-48.89%1.09M	-26.53%2.13M	2,396.01%2.91M	89.07%-126.56K	57.98%-1.16M	-220.05%-2.76M	-43.73%-1.43M	-330.24%-1.27M	122.22%194.61K	-153.49%-245.18K
Cash from discontinued investing activities
Operating cash flow	93.44%-614.48K	37.39%-9.37M	-169.81%-14.96M	36.00%-5.54M	34.53%-8.66M	45.49%-13.23M	70.09%-1.93M	15.62%-4.02M	63.37%-2.3M	26.48%-4.98M
Investing cash flow
Cash flow from continuing investing activities	100.11%2.46K	39.75%-2.31M	-44.71%-3.83M	14.44%-2.65M	-69.89%-3.1M	-1,733.98%-1.82M	-29,224.30%-1.87M	207.96%68.16K	-235.64%-19.64K	0
Net PPE purchase and sale	----	----	----	----	-196.30%-65.64K	1,166.83%68.16K	--0	----	----	--0
Net intangibles purchase and sale	----	36.48%-2.31M	-37.30%-3.64M	13.11%-2.65M	-61.27%-3.05M	-1,190.16%-1.89M	---1.87M	--0	----	----
Net business purchase and sale	----	--0	--0	----	----	----	----	----	----	----
Net investment purchase and sale	--2.46K	--0	---195.93K	----	----	----	----	----	----	----
Cash from discontinued investing activities
Investing cash flow	100.11%2.46K	39.75%-2.31M	-44.71%-3.83M	14.44%-2.65M	-69.89%-3.1M	-1,733.98%-1.82M	-29,224.30%-1.87M	207.96%68.16K	-235.64%-19.64K	--0
Financing cash flow
Cash flow from continuing financing activities	-88.77%1.19M	46.57%10.6M	-62.73%7.24M	154.95%19.41M	32.83%7.61M	-30.27%5.73M	269.82%3.91M	476.03%4.92M	-1,822.01%-6.06M	-66.28%2.96M
Net issuance payments of debt	----	8,602.26%6.39M	-104.31%-75.16K	215.42%1.74M	83.71%-1.51M	-344.27%-9.27M	-0.59%-1.07M	---1.17M	---5.61M	---1.43M
Net common stock issuance	--1.19M	----	----	----	----	----	----	--7M	--0	-43.33%5.28M
Cash dividends paid	----	--0	--0	--0	--0	--0	--0	--0	--0	--0
Proceeds from stock option exercised by employees	----	-42.91%4.27M	-59.31%7.49M	82.03%18.4M	-42.07%10.11M	--17.45M	----	----	----	----
Net other financing activities	----	77.68%-38.29K	76.47%-171.55K	25.55%-728.94K	51.21%-979.03K	-29.60%-2.01M	88.64%-149.99K	---851.69K	---349.91K	-188.00%-654.99K
Cash from discontinued financing activities
Financing cash flow	-88.77%1.19M	46.57%10.6M	-62.73%7.24M	154.95%19.41M	32.83%7.61M	-30.27%5.73M	269.82%3.91M	476.03%4.92M	-1,822.01%-6.06M	-66.28%2.96M
Net cash flow
Beginning cash position	-99.44%5.89K	-91.38%1.06M	677.13%12.32M	-71.53%1.58M	-62.83%5.57M	-53.85%14.97M	-73.97%5.26M	-83.15%4.42M	-62.61%12.65M	-53.85%14.97M
Current changes in cash	154.01%578.54K	90.73%-1.07M	-203.00%-11.56M	370.68%11.22M	55.54%-4.15M	42.29%-9.32M	102.04%110.18K	115.77%967.33K	-27.18%-8.38M	-202.57%-2.02M
Effect of exchange rate changes	-102.26%-591.7089	-91.73%26.18K	286.71%316.59K	924.31%81.87K	103.10%7.99K	80.41%-257.64K	-85.41%25.15K	-241.97%-131.22K	114.77%150.17K	46.41%-301.74K
End cash Position	3,416.07%583.84K	-98.46%16.6K	-91.65%1.08M	801.72%12.89M	-73.50%1.43M	-63.98%5.39M	-63.98%5.39M	-73.97%5.26M	-83.15%4.42M	-62.61%12.65M
Free cash flow	94.74%-614.48K	37.21%-11.68M	-126.96%-18.6M	30.43%-8.19M	22.12%-11.78M	38.09%-15.12M	41.13%-3.8M	16.88%-4.02M	63.06%-2.32M	27.28%-4.98M
Currency Unit	USD	USD	USD	USD	USD	CHF	CHF	CHF	CHF	CHF
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	Unqualified Opinion	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data